Menu
GeneBe

rs375701469

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_030662.4(MAP2K2):c.529-12G>A variant causes a splice polypyrimidine tract, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000196 in 1,573,860 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.00022 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00019 ( 0 hom. )

Consequence

MAP2K2
NM_030662.4 splice_polypyrimidine_tract, intron

Scores

2
Splicing: ADA: 0.00003217
2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 0.0730
Variant links:
Genes affected
MAP2K2 (HGNC:6842): (mitogen-activated protein kinase kinase 2) The protein encoded by this gene is a dual specificity protein kinase that belongs to the MAP kinase kinase family. This kinase is known to play a critical role in mitogen growth factor signal transduction. It phosphorylates and thus activates MAPK1/ERK2 and MAPK2/ERK3. The activation of this kinase itself is dependent on the Ser/Thr phosphorylation by MAP kinase kinase kinases. Mutations in this gene cause cardiofaciocutaneous syndrome (CFC syndrome), a disease characterized by heart defects, cognitive disability, and distinctive facial features similar to those found in Noonan syndrome. The inhibition or degradation of this kinase is also found to be involved in the pathogenesis of Yersinia and anthrax. A pseudogene, which is located on chromosome 7, has been identified for this gene. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BP6
Variant 19-4101292-C-T is Benign according to our data. Variant chr19-4101292-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 138157.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population sas. gnomad4 allele frequency = 0.000224 (34/152052) while in subpopulation SAS AF= 0.00291 (14/4814). AF 95% confidence interval is 0.00176. There are 0 homozygotes in gnomad4. There are 19 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High AC in GnomAd at 34 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
MAP2K2NM_030662.4 linkuse as main transcriptc.529-12G>A splice_polypyrimidine_tract_variant, intron_variant ENST00000262948.10
MAP2K2XM_006722799.3 linkuse as main transcriptc.529-12G>A splice_polypyrimidine_tract_variant, intron_variant
MAP2K2XM_047439100.1 linkuse as main transcriptc.-42-12G>A splice_polypyrimidine_tract_variant, intron_variant

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
MAP2K2ENST00000262948.10 linkuse as main transcriptc.529-12G>A splice_polypyrimidine_tract_variant, intron_variant 1 NM_030662.4 P1

Frequencies

GnomAD3 genomes
AF:
0.000224
AC:
34
AN:
151934
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000266
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000131
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00291
Gnomad FIN
AF:
0.0000944
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000736
Gnomad OTH
AF:
0.000481
GnomAD3 exomes
AF:
0.000554
AC:
102
AN:
184176
Hom.:
0
AF XY:
0.000580
AC XY:
57
AN XY:
98308
show subpopulations
Gnomad AFR exome
AF:
0.000187
Gnomad AMR exome
AF:
0.00138
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.000218
Gnomad SAS exome
AF:
0.00210
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000771
Gnomad OTH exome
AF:
0.000616
GnomAD4 exome
AF:
0.000193
AC:
274
AN:
1421808
Hom.:
0
Cov.:
37
AF XY:
0.000235
AC XY:
165
AN XY:
703484
show subpopulations
Gnomad4 AFR exome
AF:
0.0000611
Gnomad4 AMR exome
AF:
0.000996
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.000159
Gnomad4 SAS exome
AF:
0.00183
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000577
Gnomad4 OTH exome
AF:
0.000272
GnomAD4 genome
AF:
0.000224
AC:
34
AN:
152052
Hom.:
0
Cov.:
32
AF XY:
0.000256
AC XY:
19
AN XY:
74314
show subpopulations
Gnomad4 AFR
AF:
0.000265
Gnomad4 AMR
AF:
0.000131
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00291
Gnomad4 FIN
AF:
0.0000944
Gnomad4 NFE
AF:
0.0000736
Gnomad4 OTH
AF:
0.000476
Alfa
AF:
0.000254
Hom.:
0
Bravo
AF:
0.000249
Asia WGS
AF:
0.00115
AC:
4
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
Benign, criteria provided, single submitterclinical testingWomen's Health and Genetics/Laboratory Corporation of America, LabCorpSep 25, 2023- -
Likely benign, criteria provided, single submitterclinical testingLaboratory for Molecular Medicine, Mass General Brigham Personalized MedicineJan 16, 2015c.529-12G>A in intron 4 of MAP2K2: This variant is not expected to have clinical significance because it has been identified in 0.2% (16/8642) of South Asian ch romosomes and 0.25% (3/1192) of Latino chromosomes by the Exome Aggregation Cons ortium (ExAC, http://exac.broadinstitute.org; dbSNP rs375701469). This variant i s located in the 3' splice region and computational tools do not suggest an impa ct to splicing. -
Benign, criteria provided, single submitterclinical testingGeneDxSep 08, 2013This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
RASopathy Benign:1
Benign, criteria provided, single submitterclinical testingInvitaeJan 31, 2024- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.86
Cadd
Benign
2.3
Dann
Benign
0.60
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.000032
dbscSNV1_RF
Benign
0.0
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs375701469; hg19: chr19-4101290; API